Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
Kronox Lab Sciences Share Price
Kronox Lab Sciences Sha...
Kronox Lab Sciences share price insights
Sales de-grew by 6.21%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
Company has spent less than 1% of its operating revenues towards interest expenses and 6.93% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Kronox Lab Sciences Ltd. share price moved up by 3.05% from its previous close of Rs 176.23. Kronox Lab Sciences Ltd. stock last traded price is 181.60
Share Price Value Today/Current/Last 181.60 Previous Day 176.23
Key Metrics
PE Ratio (x) | 31.90 | ||||||||||
EPS - TTM (₹) | 5.69 | ||||||||||
MCap (₹ Cr.) | 673.81 | ||||||||||
Sectoral MCap Rank | 116 | ||||||||||
PB Ratio (x) | 9.86 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 183.37 | ||||||||||
52W H/L (₹) |
Kronox Lab Sciences Share Price Returns
1 Day | 3.05% |
1 Week | 19.67% |
1 Month | 19.47% |
3 Months | N.A. |
1 Year | N.A. |
3 Years | N.A. |
5 Years | N.A. |
Kronox Lab Sciences News & Analysis
Notice Of The 15Th Annual General Meeting
Announcements- Announcements
- Announcements
Intimation Of Record Date For Dividend
Announcements
Kronox Lab Sciences Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Kronox Lab Sciences Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 6.21%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 6.93% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 25.62 23.00 21.13 21.12 26.20 Total Income Growth (%) 11.40 8.88 0.05 -19.39 21.20 Total Expenses 17.32 14.61 14.70 15.77 17.75 Total Expenses Growth (%) 18.56 -0.66 -6.76 -11.18 -0.13 EBIT 8.31 8.40 6.42 5.35 8.44 EBIT Growth (%) -1.05 30.72 20.12 -36.66 120.10 Profit after Tax (PAT) 6.15 5.88 4.84 4.25 6.38 PAT Growth (%) 4.56 21.48 14.02 -33.44 161.82 EBIT Margin (%) 32.42 36.50 30.40 25.32 32.23 Net Profit Margin (%) 24.00 25.57 22.92 20.11 24.36 Basic EPS (₹) 1.67 1.60 1.32 1.14 1.71 All figures in Rs Cr, unless mentioned otherwise
Insights
Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 Total Assets 73.99 54.03 56.79 Total Assets Growth (%) 36.94 -4.86 50.84 Total Liabilities 7.69 9.36 16.44 Total Liabilities Growth (%) -17.84 -43.07 51.80 Total Equity 66.31 44.68 40.35 Total Equity Growth (%) 48.41 10.73 50.50 Current Ratio (x) 6.07 3.85 3.21 Total Debt to Equity (x) 0.00 0.00 0.02 Contingent Liabilities 0.18 - - All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 17.31 cr for investing activities which is an YoY increase of 213.8%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities 17.42 19.67 9.02 Net Cash used in Investing Activities -17.31 -5.52 -7.60 Net Cash flow from Financing Activities - -13.40 -0.67 Net Cash Flow 0.10 0.75 0.76 Closing Cash & Cash Equivalent 2.59 3.56 2.81 Closing Cash & Cash Equivalent Growth (%) -27.39 26.76 36.81 Total Debt/ CFO (x) 0.00 0.00 0.07 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 Return on Equity (%) 32.20 37.19 33.76 Return on Capital Employed (%) 43.13 49.63 43.60 Return on Assets (%) 28.85 30.75 23.99 Interest Coverage Ratio (x) 0.00 257.17 51.33 Asset Turnover Ratio (x) 1.40 1.72 1.74 Price to Earnings (x) - - - Price to Book (x) - - - EV/EBITDA (x) - - - EBITDA Margin (%) 33.26 25.02 25.27
Kronox Lab Sciences Peer Comparison
Kronox Lab Sciences Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Kronox Lab Sciences Board Meeting/AGM
Kronox Lab Sciences Dividends
- Others
Meeting Date Announced on Purpose Details Aug 06, 2024 Jul 29, 2024 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 5% 0.5 Aug 23, 2024 Jun 28, 2024 No other corporate actions details are available.
About Kronox Lab Sciences
Executives
Auditors
- JJ
Jogindersingh Jaswal
Chairman & Managing DirectorKRKetan Ramani
Whole Time DirectorPRPritesh Ramani
Whole Time DirectorKNKrutika Negandhi
Independent DirectorShow More - Mahesh Udhwani & Associates
Industry
Key Indices Listed on
BSE IPO Index,
Address
Block No.353, Village Ekalbara, Padra,Vadodra, Gujarat - 391440
More Details
Trending in Markets
Kronox Lab Sciences Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.